A5089277250- Hepatitis C virus research
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
- Liver Disease and Transplantation
- Renal Transplantation Outcomes and Treatments
- Systemic Lupus Erythematosus Research
- HIV/AIDS drug development and treatment
- Renal Diseases and Glomerulopathies
- Hepatitis Viruses Studies and Epidemiology
- Organ Transplantation Techniques and Outcomes
- HIV-related health complications and treatments
- Dialysis and Renal Disease Management
- Drug-Induced Hepatotoxicity and Protection
- Chronic Kidney Disease and Diabetes
- COVID-19 Clinical Research Studies
- HIV, Drug Use, Sexual Risk
- COVID-19 and healthcare impacts
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Long-Term Effects of COVID-19
- Diabetes Treatment and Management
- Liver Diseases and Immunity
- SARS-CoV-2 and COVID-19 Research
- Metabolism and Genetic Disorders
- Chronic Lymphocytic Leukemia Research
- Platelet Disorders and Treatments
Ospedale Maggiore
2015-2024
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2014-2024
Istituti di Ricovero e Cura a Carattere Scientifico
2012-2024
University of Milan
2017
University of Miami
2008-2016
Ospedali Riuniti di Foggia
2016
Alessandro Manzoni Hospital
1999-2015
Creative Research Enterprises (United States)
2015
University School
2014-2015
Icahn School of Medicine at Mount Sinai
2007
Previous studies have suggested the benefits of physical exercise for patients on dialysis. We conducted Exercise Introduction to Enhance Performance in Dialysis trial, a 6-month randomized, multicenter trial test whether simple, personalized walking program at home, managed by dialysis staff, improves functional status adult The main study outcomes included change performance 6 months, assessed 6-minute and five times sit-to-stand test, quality life, Kidney Disease Quality Life Short Form...
<b><i>Background/Aims: </i></b>Scarce physical activity predicts shorter survival in dialysis patients. However, the relationship between (motor) fitness and clinical outcomes has never been tested these <b><i>Methods: </i></b>We predictive power of an established metric motor fitness, Six-Minute Walking Test (6MWT), for death, cardiovascular events hospitalization 296 patients who took part trial EXCITE (ClinicalTrials.gov Identifier:...
Infection with the hepatitis C virus (HCV) has adverse liver, kidney, and cardiovascular consequences in patients chronic kidney disease (CKD), including those on dialysis therapy a transplant. Since publication of original Kidney Disease: Improving Global Outcomes (KDIGO) HCV Guideline 2008, major advances management, particularly advent direct-acting antiviral therapies, have now made cure possible CKD patients. In addition, diagnostic techniques evolved to enable noninvasive diagnosis...
Background Hepatorenal syndrome (HRS) is a severe complication of end-stage renal disease whose management still constitutes big challenge. Various approaches have been used for hepatorenal treatment, including vasoconstrictor therapy. Terlipressin, vasopressin analogue, has frequently used. Aim To evaluate the efficacy and safety terlipressin in patients with HRS by performing systematic review meta-analysis controlled, clinical trials. Methods Only prospective, placebo-controlled,...